Center for Personalized Medicine, University of South Florida Morsani College of Medicine, Tampa, Florida, USA.
Department of Molecular Pharmacology and Physiology, University of South Florida Morsani College of Medicine, Tampa, Florida, USA; and.
FASEB J. 2018 Jul;32(7):3680-3688. doi: 10.1096/fj.201701278R. Epub 2018 Feb 13.
β-Adrenergic receptors (βARs) desensitize during continuous agonist activation, which manifests clinically as tachyphylaxis. β-Agonist desensitization of βARs in human airway smooth muscle (HASM) cells is recognized in the treatment of asthma and may be related to poor outcomes. Rapid events in desensitization include receptor phosphorylation and internalization, but mechanisms responsible for the decrease in receptor protein after prolonged agonist exposure (down-regulation) are ill defined. The microRNA (miRNA) let-7f regulates βAR expression by translational repression. In cultured HASM cells from nonasthmatic and asthmatic lungs, 18 h of β-agonist exposure increased let-7f by 2-3-fold, concomitant with a ∼90% decrease in βARs. Inhibition of let-7f attenuated this down-regulation response by ∼50%. The let-7f increase was found to be cAMP/PKA-dependent. The mechanism of the let-7f increase was found by chromatin immunoprecipitation to be from activated cAMP response element-binding protein (CREB) binding to the let-7f promoter, thereby increasing let-7f expression. Knockdown of CREB attenuated agonist-promoted βAR down-regulation by ∼50%. Thus, βAR down-regulation occurs as a result of not only internalized receptor degradation but also a novel cAMP/PKA/CREB-mediated increase in let-7f, which causes enhanced repression of the βAR gene, adrenoreceptor β ( ADRB2) translation and represents ∼50% of the net loss of receptors observed after prolonged agonist exposure. This mechanism is apparent in asthmatic HASM cells, indicating relevance in a disease model.-Kim, D., Cho, S., Woo, J. A., Liggett, S. B. A CREB-mediated increase in miRNA let-7f during prolonged β-agonist exposure: a novel mechanism of β-adrenergic receptor down-regulation in airway smooth muscle.
β-肾上腺素能受体(βAR)在持续激动剂激活时失敏,临床上表现为快速耐受。在哮喘治疗中,已经认识到人类气道平滑肌(HASM)细胞中βAR 的β-激动剂脱敏作用,并且它可能与不良结局有关。脱敏的快速事件包括受体磷酸化和内化,但导致在延长激动剂暴露后受体蛋白减少(下调)的机制尚未明确。微小 RNA(miRNA)let-7f 通过翻译抑制来调节βAR 的表达。在来自非哮喘和哮喘肺的培养 HASM 细胞中,18 小时的β-激动剂暴露使 let-7f 增加了 2-3 倍,同时βAR 减少了约 90%。let-7f 的抑制减轻了这种下调反应约 50%。发现 let-7f 的增加是 cAMP/PKA 依赖性的。染色质免疫沉淀发现,let-7f 增加的机制是激活的 cAMP 反应元件结合蛋白(CREB)与 let-7f 启动子结合,从而增加 let-7f 的表达。CREB 的敲低使激动剂促进的βAR 下调减少了约 50%。因此,βAR 下调不仅发生在内化受体降解,还发生在新型 cAMP/PKA/CREB 介导的 let-7f 增加,这导致βAR 基因、肾上腺素受体β(ADRB2)翻译的增强抑制,并代表在延长激动剂暴露后观察到的受体净损失的约 50%。这种机制在哮喘 HASM 细胞中是明显的,表明在疾病模型中具有相关性。-Kim,D.,Cho,S.,Woo,J. A.,Liggett,S. B. 在延长的β-激动剂暴露期间,CREB 介导的 miRNA let-7f 增加:气道平滑肌中β-肾上腺素能受体下调的新机制。